The Global Meningococcal Vaccines Market Size Was Valued at USD 3.73 Billion in 2023 and is Projected to Reach USD 8.80 Billion by 2032, Growing at a CAGR of 10.02%.
Meningococcal vaccines are critical biological preparations designed to protect individuals against diseases caused by the bacterium Neisseria meningitidis, which can lead to life-threatening conditions like meningitis and...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek